Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001237401-26-000002
Filing Date
2026-06-30
Accepted
2026-06-30 16:04:23
Documents
1
Period of Report
2026-06-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6038
  Complete submission text file 0001237401-26-000002.txt   7447
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302
Business Address
HASTINGS DAVID C (Reporting) CIK: 0001237401 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 261140461